TABLE 1. Clinical and epidemiological characteristics of human immunodeficiency virus (HIV)/Leishmania coinfected patients.
Coinfected group | Gender | Age (year) | CD4+ T-cell count (cell/mm3) | Viral load (log copies/mL) | ART use | Leishmaniasis form |
TL/HIV 03 | F | 42 | 93 | 5.4 | Unknown | Mucocutaneous active |
TL/HIV 05 | F | 22 | 291 | 1.9 | Unknown | Cutaneous active |
TL/HIV 06 | M | 36 | 165 | 5.3 | Unknown | Cutaneous treated |
TL/HIV 08 | F | 62 | 415 | 2.7 | Yes | Disseminated cutaneous treated |
TL/HIV 09 | M | 59 | 78 | 5.0 | Yes | Cutaneous active |
TL/HIV 12 | M | 36 | 615 | 1.9 | Yes | Cutaneous active |
TL/HIV 13 | M | 36 | 104 | 5.0 | No | Cutaneous active treated |
TL/HIV 14 | M | 25 | 241 | 4.6 | Yes | Mucocutaneous active |
ART: antiretroviral treatment; F: female; M: male; TL: tegumentary leishmaniasis.